4

KemPharm® is a rare disease therapeutics company focused on the discovery, development and commercialization of novel treatments for rare CNS and neurodegenerative diseases, lysosomal storage disorders and related treatment areas.

SEC Filing Details

Document Details

Form
Filing Date
Jan 11, 2023
Document Date
Jan 9, 2023
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
KemPharm
Issuer
KEMPHARM, INC
Filer
Pascoe Richard W